Journal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 17, Issue 11, Pages -Publisher
SPRINGER
DOI: 10.1007/s11910-017-0793-3
Keywords
Electrical impedance; Muscle; Myopathy; Neurogenic disease; Disuse; Injury
Categories
Funding
- National Institutes of Health [R01 NS055099, K24NS060951]
Ask authors/readers for more resources
Purpose of Review In this article, we provide an overview of electrical impedance myography (EIM), including its technical and theoretical basis, a summary of its varied applications, and ongoing developments. Recent Findings EIMhas been used as a disease severity biomarker in a variety of disorders affecting the muscle, ranging from amyotrophic lateral sclerosis (ALS) to muscular dystrophies to disuse atrophy due to the weightlessness of space. In ALS, studies have demonstrated that major reductions in sample size in clinical trials can be achieved. Similarly, in the Duchenne muscular dystrophy, the technique tracks disease progression and is sensitive to the beneficial effect of steroids. More basic work has demonstrated that EIM can provide a non-invasive means of tracking muscle fiber size. Ongoing innovations include the development of techniques for assessing muscle contraction. Summary EIM is gradually being adopted as a useful, practical, and convenient tool for the assessment of neuromuscular conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available